[1] |
YANG Yifan, YANG Yanwei, ZHANG Di, XIE Yin, ZHANG Yong, CHEN Xulin, GAO Sutao, GENG Xingchao, QU Zhe.
Quality Control and Test Methods of Human Induced Pluripotent Stem Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 728-734.
|
[2] |
CAO Kai, QIAN Peipei, GAO Xin, YANG Futian, ZHAO Liang, XU Bingxin, ZHANG Xianjun.
Mining of Risk Signals Adverse Events Related to Drug-Induced Salivary Gland Calculus Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 799-804.
|
[3] |
LIU Sihan, PEI Yusheng, TAN Dejiang, SUN Huimin, ZHANG Heng, LIU Tao, WANG Dongmei, HE Qing.
Research Progress in Detection Methods of Pyrogen and Bacterial Endotoxin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 361-367.
|
[4] |
ZHAO Yuxin, CAI Tong, SUN Huimin, LIU Tao, PEI Yusheng, XU Huarong.
Testing Methods for Bacterial Endotoxin in a Pharmaceutical Excipient of Trimethyl-Phloroglucinol
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 368-371.
|
[5] |
CHEN Chen, ZHAO Xiaoyan, CAI Tong, PEI Yusheng.
Detection of Bacterial Endotoxin in Recombinant Follicle-Stimulating Hormone β Injection Using Gel-Clot Method and Recombinant C-Factor Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 372-376.
|
[6] |
CHEN Lingbin, HUANG Zhixiong, ZHENG Cailin, WU Jinneng, CHEN Zhou.
Adverse Event Signals for Osimertinib-Induced Muscle Toxicity Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 447-451.
|
[7] |
LIU Bo, YUAN Yanan, WANG Yue, CHENG Shuqian, LU Zhiguo, FAN Huihong, SUN Huimin.
Key Technologies for Quality Control of Oligonucleotide Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 1-9.
|
[8] |
SUN Deyang, SUN Jiabei, LI Wenlong, JIA Juanjuan, ZHANG Wenzai, LIU Yan, HUANG Haiwei, YAO Jing.
Assignment of Chemical Reference Substance of Aminopolyether -a Key Impurity in Fludeoxyglucose [18F] Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 43-46.
|
[9] |
PEI Yusheng, XU Lin, ZHAO Yuxin, CAI Tong, HUA Xiaodong.
Low Endotoxin Recovery and Mitigation Strategies
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 72-75.
|
[10] |
ZHAO Peipei, WEN Baoshu.
Regulation of cellular and gene therapies at home and abroad
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1019-1024.
|
[11] |
ZHANG Chenxue, CAI Tong, CHEN Chen, LIU Tao, LI Wenlong, PEI Yusheng.
Study of a microgel method for the examination of bacterial endotoxins
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 841-846.
|
[12] |
YANG Yuxi, PEI Yusheng, LIU Tao, GAO Hua, CAI Tong.
Current situation and reflection on limulus amebocyte lysate and recombinant reagents for testing
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 847-851.
|
[13] |
XU Meibao, PEI Yusheng, CHEN Chen, LI Wenlong, LIU Tao, CAI Tong.
Bacterial endotoxin test of (R)-lansoprazole raw material
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 852-856.
|
[14] |
ZHONG Hong, CHEN Hong, ZHANG Xuanyi, DENG Huiyuan, LUO Xianglin, WAN Jie, KONG Wenqiang.
Detection and analysis of signals of adverse events induced by deferasirox based on FAERS
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 931-935.
|
[15] |
ZHANG Chenxue, PEI Yusheng, CAI Tong.
Research progress in bacterial endotoxin test methods for insoluble raw materials, excipients and preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 273-279.
|